Research Spotlight: Lower Hydroxychloroquine Dosing is Less Effective in Preventing Lupus Flares
Hydroxychloroquine dosing under 5 mg/kg/day is less effective in preventing lupus flares than higher dosing.
Learn more about the Massachusetts General Hospital Division of Plastic and Reconstructive Surgery's surgical options for painful joints.
The Dermatology-Rheumatology Connective Tissue Disease Program provides comprehensive care for patients with autoimmune skin and joint disease such as dermatomyositis, lupus and scleroderma.
Pediatric rheumatologists at Mass General for Children specialize in the diagnosis and treatment of all rheumatic and inflammatory conditions of infants, children, and adolescents.
Department of Medicine
The Pulmonary Hypertension and Thromboendarterectomy Program at Massachusetts General Hospital is committed to the state-of-the-art evaluation, treatment and support of patients with all forms of pulmonary hypertension.
Read the latest news from Massachusetts General Hospital.
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
A podcast devoted to uncovering the stories of Mass General's relentless pursuit to break boundaries and provide exceptional care
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.